Home Cart Sign in  
Chemical Structure| 781661-94-7 Chemical Structure| 781661-94-7

Structure of Sepantronium bromide
CAS No.: 781661-94-7

Chemical Structure| 781661-94-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

YM155 is an inhibitor of survivin with IC50 of 0.54 nM.

Synonyms: YM-155

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Shahab, Samaneh ; Ramírez-Cárdenas, Jonathan ; Angulo, Jesús ; Angulo, Gonzalo ; Pastorczak, Marcin ;

Abstract: Sepantronium bromide, which shows a broad spectrum of anticancer action, is allegedly chemically unstable. This instability might significantly limit the final antineoplastic efficacy of the drug. Here, we report our studies on these chemical stability issues under different chemical environments using advanced spectroscopies. With UV–Vis spectroscopy, we observed a degradation product which absorbs around 450 nm. The degradation accelerated strongly at alkaline pH (>8.5) and in the presence of a buffer, particularly PBS. We performed NMR and stimulated Raman studies to identify the degradation product and analysed the degradation kinetics. With both methods, we observed H → D isotope exchange at the methyl group linked to the imidazole group of YM155, after dissolving YM155 in D2O. The exchange was similarly both alkaline- and buffer-catalysed. We were unable to identify the 450 nm-absorbing product of the degradation neither by NMR nor stimulated Raman, yet our studies pointed at imidazole-linked methyl as being associated with the YM155 degradation. The alkaline degradation of YM155 could be related to its mechanism of action – binding to DNA in mitochondria with pH values above 8.

Purchased from AmBeed:

Alternative Products

Product Details of Sepantronium bromide

CAS No. :781661-94-7
Formula : C20H19BrN4O3
M.W : 443.29
SMILES Code : [Br-].O=C1C=2C=CC=CC2C(=O)C3=C1N(C(=[N+]3CC4=NC=CN=C4)C)CCOC
Synonyms :
YM-155
MDL No. :MFCD11983133
InChI Key :QBIYUDDJPRGKNJ-UHFFFAOYSA-M
Pubchem ID :11178236

Safety of Sepantronium bromide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Survivin

    Survivin, IC50:0.54 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
UKF-NB-3 0.49 nM 120 h YM155 affects the viability of drug-resistant neuroblastoma cells through survivin depletion and p53 activation. Cell Death Dis. 2016 Oct 13;7(10):e2410.
UKF-NB-6 0.65 nM 120 h YM155 affects the viability of drug-resistant neuroblastoma cells through survivin depletion and p53 activation. Cell Death Dis. 2016 Oct 13;7(10):e2410.
CAL27 cells 12.7 nM 24 h YM155 induced apoptosis in CAL27 cells in a mitochondria and death receptor-dependent manner, and significantly enhanced autophagy, leading to cell death Cell Death Dis. 2015 May 28;6(5):e1771.
HSC3 cells 19.1 nM 24 h YM155 induced apoptosis in HSC3 cells in a mitochondria and death receptor-dependent manner, and significantly enhanced autophagy, leading to cell death Cell Death Dis. 2015 May 28;6(5):e1771.
U251 cells 5 nM 48 h To evaluate the effects of YM155 on the proliferation and radiosensitivity of U251 cells, the results showed that YM155 reduced cell viability and enhanced radiosensitivity. J Transl Med. 2018 Mar 23;16(1):79.
U87 cells 5 nM 48 h To evaluate the effects of YM155 on the proliferation and radiosensitivity of U87 cells, the results showed that YM155 reduced cell viability and enhanced radiosensitivity. J Transl Med. 2018 Mar 23;16(1):79.
KBM7 cells 100 nM 3 days To validate the dependency of YM155 on SLC35F2, results showed that cells lacking SLC35F2 were significantly less sensitive to YM155. Nat Chem Biol. 2014 Sep;10(9):768-773.
Healthy human peripheral blood mononuclear cells (PBMCs) 100 nM 24 h To evaluate the effect of YM155 on T cell apoptosis, results showed that YM155 increased T cell apoptosis. Front Immunol. 2021 Aug 6;12:710904.
HeLa cells 25 nM 24 h The cell viability assay was used to screen the sensitivity of USP32 knockout to YM155, and it was found that USP32 knockout increased sensitivity to YM155. Theranostics. 2021 Sep 27;11(20):9752-9771.
PC3 cells 10 nM 16 h To investigate the effect of Sepantronium on oxygen consumption in PC3 cells, the results showed that Sepantronium significantly inhibited oxygen consumption. Sci Signal. 2015 Aug 11;8(389):ra80.
PC3 cells 10 nM 16 h To investigate the effect of Sepantronium on ATP production in PC3 cells, the results showed that Sepantronium significantly reduced ATP production. Sci Signal. 2015 Aug 11;8(389):ra80.
PC3 cells 10 nM 16 h To investigate the effect of Sepantronium on Complex II activity in PC3 cells, the results showed that Sepantronium significantly inhibited Complex II activity. Sci Signal. 2015 Aug 11;8(389):ra80.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CAL27 xenograft and transgenic HNSCC mouse models Intraperitoneal injection 5 mg/kg Twice per week for 2 weeks YM155 displayed potent antitumor activities in both CAL27 xenograft and transgenic HNSCC mouse models by delaying tumor onset and suppressing tumor growth Cell Death Dis. 2015 May 28;6(5):e1771.
Nude mice Orthotopic glioblastoma model Intratumoral injection 5 mg/kg Twice a week, total of five injections To evaluate the effects of YM155 combined with radiotherapy on the survival and tumor growth in a glioblastoma mouse model, the results showed that combination therapy significantly prolonged survival and inhibited tumor growth. J Transl Med. 2018 Mar 23;16(1):79.
Mice SW480 cell xenograft model Subcutaneous injection 10 mg/kg Once daily for 7 days To validate the impact of SLC35F2 expression levels on YM155 efficacy in vivo, results showed that tumors with high SLC35F2 expression were more sensitive to YM155. Nat Chem Biol. 2014 Sep;10(9):768-773.
Mice Acute heart transplant rejection model Intraperitoneal injection 5 mg/kg Administered on days -1, 1, 3, 5 To evaluate the effect of YM155 on acute heart transplant rejection, results showed that YM155 prolonged graft survival and reduced inflammatory cell infiltration. Front Immunol. 2021 Aug 6;12:710904.
NOD scid γ (NSG) mice Breast cancer xenograft model Intraperitoneal injection 7.5 mg/kg Twice a week until the end of the experiment The xenograft model was used to validate the effect of USP32 knockout on the anti-tumor efficacy of YM155, and it was found that USP32 knockout significantly reduced tumor volume and weight. Theranostics. 2021 Sep 27;11(20):9752-9771.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.28mL

2.26mL

1.13mL

22.56mL

4.51mL

2.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories